Skip to main content
Top
Published in: Metabolic Brain Disease 3/2018

01-06-2018 | Review Article

The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction

Authors: Titikorn Chunchai, Nipon Chattipakorn, Siriporn C. Chattipakorn

Published in: Metabolic Brain Disease | Issue 3/2018

Login to get access

Abstract

Obesity has reached epidemic proportions in many countries around the world. Several studies have reported that obesity can lead to the development of cognitive decline. There is increasing evidence to demonstrate that microglia play a crucial role in cognitive decline in cases of obesity, Alzheimer’s disease and also in the aging process. Although there have been several studies into microglia over the past decades, the mechanistic link between microglia and cognitive decline in obese models is still not fully understood. In this review, the current available evidence from both in vitro and in vivo investigations regarding the association between the alteration in microglial activity in different obese models with respect to cognition are included. The metabolite profiles from obesity, adiposity, dietary and hormone affected microglial activation and its function in the brain are comprehensively summarized. In addition, the possible roles of microglial activation in relation to cognitive dysfunction are also presented and discussed. To ensure a balanced perspective controversial reports regarding these issues are included and discussed.
Literature
go back to reference Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, Nissbrandt H, Berqquist F, Gribble FM, Reimann F, Wernstedt Asterholm I, Lamy CM, Skibicka KP (2017) Glucagon-like Peptide-1 and its analogues act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes 66(4):1062–1073. https://doi.org/10.2337/db16-0755 CrossRefPubMed Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, Nissbrandt H, Berqquist F, Gribble FM, Reimann F, Wernstedt Asterholm I, Lamy CM, Skibicka KP (2017) Glucagon-like Peptide-1 and its analogues act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes 66(4):1062–1073. https://​doi.​org/​10.​2337/​db16-0755 CrossRefPubMed
go back to reference Brocca ME, Pietranera L, Meyer M, Lima A, Roig P, de Kloet ER, De Nicola AF (2017) Mineralocorticoid receptor associates with pro-inflammatory bias in hippocampus of spontaneously hypertensive rats. J Neuroendocrinol 29(7). https://doi.org/10.1111/jne.12489 Brocca ME, Pietranera L, Meyer M, Lima A, Roig P, de Kloet ER, De Nicola AF (2017) Mineralocorticoid receptor associates with pro-inflammatory bias in hippocampus of spontaneously hypertensive rats. J Neuroendocrinol 29(7). https://​doi.​org/​10.​1111/​jne.​12489
go back to reference Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772. https://doi.org/10.2337/db06-1491 CrossRefPubMed Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772. https://​doi.​org/​10.​2337/​db06-1491 CrossRefPubMed
go back to reference Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvarajah JR, Hulme S, Georgiou RF, Hinz R, Gerhard A, Vail A, Prenant C, Julyan P, Maroy R, Brown G, Smigova A, Herholz K, Kassiou M, Crossman D, Francis S, Proctor SD, Russell JC, Hopkins SJ, Tyrrell PJ, Rothwell NJ, Allan SM (2011) Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 25:1113–1122. https://doi.org/10.1016/j.bbi.2011.02.008 CrossRefPubMedPubMedCentral Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvarajah JR, Hulme S, Georgiou RF, Hinz R, Gerhard A, Vail A, Prenant C, Julyan P, Maroy R, Brown G, Smigova A, Herholz K, Kassiou M, Crossman D, Francis S, Proctor SD, Russell JC, Hopkins SJ, Tyrrell PJ, Rothwell NJ, Allan SM (2011) Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 25:1113–1122. https://​doi.​org/​10.​1016/​j.​bbi.​2011.​02.​008 CrossRefPubMedPubMedCentral
go back to reference Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, Mirhafez SR, Moohebati M, Esmaily H, Ghazavi H, Saberi Karimian M, Parizadeh SMR, Mohammadi M, Mohaddes Ardabili H, Ferns GA, Ghayour-Mobarhan M (2016) Association of Serum hs-CRP levels with the presence of obesity, diabetes mellitus, and other cardiovascular risk factors. J Clin Lab Anal 30:672–676. https://doi.org/10.1002/jcla.21920 CrossRefPubMed Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, Mirhafez SR, Moohebati M, Esmaily H, Ghazavi H, Saberi Karimian M, Parizadeh SMR, Mohammadi M, Mohaddes Ardabili H, Ferns GA, Ghayour-Mobarhan M (2016) Association of Serum hs-CRP levels with the presence of obesity, diabetes mellitus, and other cardiovascular risk factors. J Clin Lab Anal 30:672–676. https://​doi.​org/​10.​1002/​jcla.​21920 CrossRefPubMed
go back to reference Gao Y, Ottaway N, Schriever SC, Legutko B, García-Cáceres C, de la Fuente E, Mergen C, Bour S, Thaler JP, Seeley RJ, Filosa J, Stern JE, Perez-Tilve D, Schwartz MW, Tschöp MH, Yi CX (2014) Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62:17–25. https://doi.org/10.1002/glia.22580 CrossRefPubMed Gao Y, Ottaway N, Schriever SC, Legutko B, García-Cáceres C, de la Fuente E, Mergen C, Bour S, Thaler JP, Seeley RJ, Filosa J, Stern JE, Perez-Tilve D, Schwartz MW, Tschöp MH, Yi CX (2014) Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62:17–25. https://​doi.​org/​10.​1002/​glia.​22580 CrossRefPubMed
go back to reference Inoue T, Tanaka M, Masuda S, Ohue-Kitano R, Yamakage H, Muranaka K, Wada H, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N (2017) Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. Biochim Biophys Acta 1862(5):552–560. https://doi.org/10.1016/j.bbalip.2017.02.010 Inoue T, Tanaka M, Masuda S, Ohue-Kitano R, Yamakage H, Muranaka K, Wada H, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N (2017) Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. Biochim Biophys Acta 1862(5):552–560. https://​doi.​org/​10.​1016/​j.​bbalip.​2017.​02.​010
go back to reference Pipatpiboon N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2012) PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 153:329–338. https://doi.org/10.1210/en.2011-1502 CrossRefPubMed Pipatpiboon N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2012) PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 153:329–338. https://​doi.​org/​10.​1210/​en.​2011-1502 CrossRefPubMed
go back to reference Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2013) DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci 37:839–849. https://doi.org/10.1111/ejn.12088 CrossRefPubMed Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2013) DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci 37:839–849. https://​doi.​org/​10.​1111/​ejn.​12088 CrossRefPubMed
go back to reference Pratchayasakul W, Sa-nguanmoo P, Sivasinprasasn S, Pintana H, Tawinvisan R, Sripetchwandee J, Kumfu S, Chattipakorn N, Chattipakorn SC (2015) Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Horm Behav 72:68–77. https://doi.org/10.1016/j.yhbeh.2015.04.023 CrossRefPubMed Pratchayasakul W, Sa-nguanmoo P, Sivasinprasasn S, Pintana H, Tawinvisan R, Sripetchwandee J, Kumfu S, Chattipakorn N, Chattipakorn SC (2015) Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Horm Behav 72:68–77. https://​doi.​org/​10.​1016/​j.​yhbeh.​2015.​04.​023 CrossRefPubMed
go back to reference Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, Bender D, Moestrup SK, Romero-Ramos M (2016) Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson's disease model. J Neurosci Off J Soc Neurosci 36:9375–9390. https://doi.org/10.1523/JNEUROSCI.1636-16.2016 CrossRef Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, Bender D, Moestrup SK, Romero-Ramos M (2016) Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson's disease model. J Neurosci Off J Soc Neurosci 36:9375–9390. https://​doi.​org/​10.​1523/​JNEUROSCI.​1636-16.​2016 CrossRef
go back to reference Vaughn AC, Cooper EM, DiLorenzo PM, O'Loughlin LJ, Konkel ME, Peters JH, Hajnal A, Sen T, Lee SH, de la Serre CB, Czaja K (2017) Energy-dense diet triggers changes in gut microbiota, reorganization of gutbrain vagal communication and increases body fat accumulation. Acta Neurobiol Exp (Wars) 77:18–30 Vaughn AC, Cooper EM, DiLorenzo PM, O'Loughlin LJ, Konkel ME, Peters JH, Hajnal A, Sen T, Lee SH, de la Serre CB, Czaja K (2017) Energy-dense diet triggers changes in gut microbiota, reorganization of gutbrain vagal communication and increases body fat accumulation. Acta Neurobiol Exp (Wars) 77:18–30
go back to reference Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG (2011) B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17:610–617. https://doi.org/10.1038/nm.2353 CrossRefPubMedPubMedCentral Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG (2011) B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17:610–617. https://​doi.​org/​10.​1038/​nm.​2353 CrossRefPubMedPubMedCentral
go back to reference Yang J, Kim CS, Tu T, Kim MS, Goto T, Kawada T, Choi MS, Park T, Sung MK, Yun J, Choe SY, Lee J, Joe Y, Choi HS, Back S, Chung H, Yu R (2017) Quercetin protects obesity-induced hypothalamic inflammation by reducing microglia-mediated inflammatory responses via HO-1 induction. Nutrients 9. https://doi.org/10.3390/nu9070650 Yang J, Kim CS, Tu T, Kim MS, Goto T, Kawada T, Choi MS, Park T, Sung MK, Yun J, Choe SY, Lee J, Joe Y, Choi HS, Back S, Chung H, Yu R (2017) Quercetin protects obesity-induced hypothalamic inflammation by reducing microglia-mediated inflammatory responses via HO-1 induction. Nutrients 9. https://​doi.​org/​10.​3390/​nu9070650
Metadata
Title
The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction
Authors
Titikorn Chunchai
Nipon Chattipakorn
Siriporn C. Chattipakorn
Publication date
01-06-2018
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 3/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0151-9

Other articles of this Issue 3/2018

Metabolic Brain Disease 3/2018 Go to the issue